SHILPAMED · NSE
Not in active coverage. Cited reporting has mentioned Shilpa Medicare, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Bliss GVS Pharma has surged 362% over the past year, while Ind-Swift Laboratories, Sakar Healthcare, Shilpa Medicare and Kwality Pharmaceuticals have jumped 281%, 217%, 149% and 282%, respectively.
Shilpa Medicare stated that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at Unit VII of its Analytical Services Division in Hyderabad from September 16 to 18, 2026, which concluded with one procedural observation.
Shilpa Medicare Ltd announced that a USFDA surveillance inspection at its Analytical Services Division in Hyderabad concluded with one procedural observation.
Shilpa Medicare announced that the Subject Expert Committee under the Central Drugs Standard Control Organization has issued final approval for grant of marketing authorization for OERIS™ (Ondansetron Extended-Release Injection, 100 mg/mL).
Shilpa Medicare has received final approval from the Subject Expert Committee under the Central Drugs Standard Control Organization to market its extended-release ondansetron injection, OERIS, in India.
Shilpa Medicare is undertaking a voluntary recall of over 27,000 vials of chemotherapy drug Pemetri RTU in the US following market complaints reporting green to dark-green discoloration in certain vials.
This page lists where cited reporting has mentioned Shilpa Medicare. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.